An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension

Marc A. Simon, Kate Hanrott, David C. Budd, Fernando Torres, Ekkehard Grünig, Pilar Escribano-Subias, Manuel L. Meseguer, Michael Halank, Christian Opitz, David A. Hall, Deborah Hewens, William M. Powley, Sarah Siederer, Andrew Bayliffe, Aili L. Lazaar, Anthony Cahn, Stephan Rosenkranz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension'. Together they form a unique fingerprint.

Medicine & Life Sciences